Click here to get full coverage on BYSI Stock Shows Turbulence Amid Financial Uncertainty - StocksToTrade

BYSI Stock Shows Turbulence Amid Financial Uncertainty  StocksToTrade

BYSI Stock Shows Turbulence Amid Financial Uncertainty - StocksToTrade

Click here to get full coverage on BeyondSpring (NASDAQ: BYSI) Phase 3 Asian data shows HR 0.69, cuts neutropenia to 3.9% - Stock Titan

BeyondSpring (NASDAQ: BYSI) Phase 3 Asian data shows HR 0.69, cuts neutropenia to 3.9%  Stock Titan

BeyondSpring (NASDAQ: BYSI) Phase 3 Asian data shows HR 0.69, cuts neutropenia to 3.9% - Stock Titan

Click here to get full coverage on BeyondSpring Inc. (NASDAQ:BYSI) Sees Large Increase in Short Interest - MarketBeat

BeyondSpring Inc. (NASDAQ:BYSI) Sees Large Increase in Short Interest  MarketBeat

BeyondSpring Inc. (NASDAQ:BYSI) Sees Large Increase in Short Interest - MarketBeat

Click here to get full coverage on Can BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth? - Yahoo Finance

Can BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth?  Yahoo Finance

Can BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth? - Yahoo Finance

Click here to get full coverage on We Think BeyondSpring (NASDAQ:BYSI) Needs To Drive Business Growth Carefully - simplywall.st

We Think BeyondSpring (NASDAQ:BYSI) Needs To Drive Business Growth Carefully  simplywall.st

We Think BeyondSpring (NASDAQ:BYSI) Needs To Drive Business Growth Carefully - simplywall.st

Click here to get full coverage on Ideas Watch: What are the future prospects of Valvoline Inc - July 2025 Movers & AI Enhanced Execution Alerts - baoquankhu1.vn

Ideas Watch: What are the future prospects of Valvoline Inc - July 2025 Movers & AI Enhanced Execution Alerts  baoquankhu1.vn

Ideas Watch: What are the future prospects of Valvoline Inc - July 2025 Movers & AI Enhanced Execution Alerts - baoquankhu1.vn

Click here to get full coverage on 12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session  Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Click here to get full coverage on Decheng Capital sells BeyondSpring (BYSI) shares for $35,965 - Investing.com

Decheng Capital sells BeyondSpring (BYSI) shares for $35,965  Investing.com

Decheng Capital sells BeyondSpring (BYSI) shares for $35,965 - Investing.com

Click here to get full coverage on BYSI: BeyondSpring's Plinabulin Shows Promising Results in Phase 3 Trial - GuruFocus

BYSI: BeyondSpring's Plinabulin Shows Promising Results in Phase 3 Trial  GuruFocus

BYSI: BeyondSpring's Plinabulin Shows Promising Results in Phase 3 Trial - GuruFocus

Click here to get full coverage on How BYSI stock benefits from global expansion - July 2025 Snapshot & Daily Growth Stock Investment Tips - Улправда

How BYSI stock benefits from global expansion - July 2025 Snapshot & Daily Growth Stock Investment Tips  Улправда

How BYSI stock benefits from global expansion - July 2025 Snapshot & Daily Growth Stock Investment Tips - Улправда

Click here to get full coverage on BeyondSpring (BYSI) Stock :Surges 5% as New Plinabulin Data Strengthens Case for Global NSCLC Registration Path - CoinCentral

BeyondSpring (BYSI) Stock :Surges 5% as New Plinabulin Data Strengthens Case for Global NSCLC Registration Path  CoinCentral

BeyondSpring (BYSI) Stock :Surges 5% as New Plinabulin Data Strengthens Case for Global NSCLC Registration Path - CoinCentral

Click here to get full coverage on BeyondSpring Announces Positive Phase 3 DUBLIN-3 Results for Plinabulin in NSCLC Patients Post Anti-PD-(L)1 Therapy and Plans for Global DUBLIN-4 Trial - Quiver Quantitative

BeyondSpring Announces Positive Phase 3 DUBLIN-3 Results for Plinabulin in NSCLC Patients Post Anti-PD-(L)1 Therapy and Plans for Global DUBLIN-4 Trial  Quiver Quantitative

BeyondSpring Announces Positive Phase 3 DUBLIN-3 Results for Plinabulin in NSCLC Patients Post Anti-PD-(L)1 Therapy and Plans for Global DUBLIN-4 Trial - Quiver Quantitative

Click here to get full coverage on BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path - GlobeNewswire

BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path  GlobeNewswire

BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path - GlobeNewswire

Click here to get full coverage on BYSI’s Stock Roller Coaster: What Happens Next? - StocksToTrade

BYSI’s Stock Roller Coaster: What Happens Next?  StocksToTrade

BYSI’s Stock Roller Coaster: What Happens Next? - StocksToTrade

Click here to get full coverage on BeyondSpring (NASDAQ: BYSI) now expects SEED share Second Closings in 1H 2026 - Stock Titan

BeyondSpring (NASDAQ: BYSI) now expects SEED share Second Closings in 1H 2026  Stock Titan

BeyondSpring (NASDAQ: BYSI) now expects SEED share Second Closings in 1H 2026 - Stock Titan

Click here to get full coverage on BeyondSpring (NASDAQ:BYSI) Trading Down 4.2% - Should You Sell? - MarketBeat

BeyondSpring (NASDAQ:BYSI) Trading Down 4.2% - Should You Sell?  MarketBeat

BeyondSpring (NASDAQ:BYSI) Trading Down 4.2% - Should You Sell? - MarketBeat

Click here to get full coverage on BYSI: Recent Business Developments Shape Market Outlook - StocksToTrade

BYSI: Recent Business Developments Shape Market Outlook  StocksToTrade

BYSI: Recent Business Developments Shape Market Outlook - StocksToTrade

Click here to get full coverage on BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025 - Stock Titan

BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025  Stock Titan

BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025 - Stock Titan

Click here to get full coverage on BYSI Stock Volatility Amidst Strategic Developments and Market Shifts - StocksToTrade

BYSI Stock Volatility Amidst Strategic Developments and Market Shifts  StocksToTrade

BYSI Stock Volatility Amidst Strategic Developments and Market Shifts - StocksToTrade

Click here to get full coverage on BeyondSpring Inc. Stock Shows Upward Spike As Earnings Report Uncovers Surprises - StocksToTrade

BeyondSpring Inc. Stock Shows Upward Spike As Earnings Report Uncovers Surprises  StocksToTrade

BeyondSpring Inc. Stock Shows Upward Spike As Earnings Report Uncovers Surprises - StocksToTrade

Click here to get full coverage on Is BYSI stock a safe haven asset - Market Trend Report & Risk Controlled Daily Plans - Улправда

Is BYSI stock a safe haven asset - Market Trend Report & Risk Controlled Daily Plans  Улправда

Is BYSI stock a safe haven asset - Market Trend Report & Risk Controlled Daily Plans - Улправда

Click here to get full coverage on BeyondSpring’s Stock Gains Steam Amid Market Developments - timothysykes.com

BeyondSpring’s Stock Gains Steam Amid Market Developments  timothysykes.com

BeyondSpring’s Stock Gains Steam Amid Market Developments - timothysykes.com

Click here to get full coverage on BeyondSpring Stock Faces Challenges Amid Recent Market Dynamics - timothysykes.com

BeyondSpring Stock Faces Challenges Amid Recent Market Dynamics  timothysykes.com

BeyondSpring Stock Faces Challenges Amid Recent Market Dynamics - timothysykes.com

Click here to get full coverage on BeyondSpring Inc. Announces Preferred Share Purchase Agreement - TradingView — Track All Markets

BeyondSpring Inc. Announces Preferred Share Purchase Agreement  TradingView — Track All Markets

BeyondSpring Inc. Announces Preferred Share Purchase Agreement - TradingView — Track All Markets

Click here to get full coverage on Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket  Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Click here to get full coverage on Beyondspring Delays Second Closings of Share Sale - TipRanks

Beyondspring Delays Second Closings of Share Sale  TipRanks

Beyondspring Delays Second Closings of Share Sale - TipRanks

Click here to get full coverage on BeyondSpring stock rises after positive Asian subset data from lung cancer trial - Investing.com UK

BeyondSpring stock rises after positive Asian subset data from lung cancer trial  Investing.com UK

BeyondSpring stock rises after positive Asian subset data from lung cancer trial - Investing.com UK

Click here to get full coverage on BeyondSpring Announces $35.4 Million Sale of a Portion of - GlobeNewswire

BeyondSpring Announces $35.4 Million Sale of a Portion of  GlobeNewswire

BeyondSpring Announces $35.4 Million Sale of a Portion of - GlobeNewswire

Click here to get full coverage on CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation - PR Newswire

CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation  PR Newswire

CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation - PR Newswire

Click here to get full coverage on Cambodia scam ring: S’porean boss of car leasing firm held as US money laundering probe widens - The Straits Times

Cambodia scam ring: S’porean boss of car leasing firm held as US money laundering probe widens  The Straits Times

Cambodia scam ring: S’porean boss of car leasing firm held as US money laundering probe widens - The Straits Times

Click here to get full coverage on SEED Receives FDA Rare Pediatric Disease and Orphan Drug - GlobeNewswire

SEED Receives FDA Rare Pediatric Disease and Orphan Drug  GlobeNewswire

SEED Receives FDA Rare Pediatric Disease and Orphan Drug - GlobeNewswire

Click here to get full coverage on BeyondSpring Stock Nearly Triples As Cancer Drug Tops Chemotherapy - Investor's Business Daily

BeyondSpring Stock Nearly Triples As Cancer Drug Tops Chemotherapy  Investor's Business Daily

BeyondSpring Stock Nearly Triples As Cancer Drug Tops Chemotherapy - Investor's Business Daily

Click here to get full coverage on BeyondSpring (BYSI) Stock Is a Good Investment, Wait for Better Price - Market Realist

BeyondSpring (BYSI) Stock Is a Good Investment, Wait for Better Price  Market Realist

BeyondSpring (BYSI) Stock Is a Good Investment, Wait for Better Price - Market Realist

Click here to get full coverage on BeyondSpring (BYSI) - Zacks Investment Research

BeyondSpring (BYSI)  Zacks Investment Research

BeyondSpring (BYSI) - Zacks Investment Research

Click here to get full coverage on BYSI Stock Price and Chart — NASDAQ:BYSI - TradingView — Track All Markets

BYSI Stock Price and Chart — NASDAQ:BYSI  TradingView — Track All Markets

BYSI Stock Price and Chart — NASDAQ:BYSI - TradingView — Track All Markets

Click here to get full coverage on New initiative launched to empower Black youth in Edmonton - CBC

New initiative launched to empower Black youth in Edmonton  CBC

New initiative launched to empower Black youth in Edmonton - CBC

Click here to get full coverage on BeyondSpring (BYSI) Stock Price, News & Analysis - MarketBeat

BeyondSpring (BYSI) Stock Price, News & Analysis  MarketBeat

BeyondSpring (BYSI) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on BeyondSpring lurches down as FDA rejects plinabulin, raising questions about lung cancer prospects - Fierce Biotech

BeyondSpring lurches down as FDA rejects plinabulin, raising questions about lung cancer prospects  Fierce Biotech

BeyondSpring lurches down as FDA rejects plinabulin, raising questions about lung cancer prospects - Fierce Biotech

Click here to get full coverage on Indoor soccer registration now open in the Battlefords - battlefordsNOW

Indoor soccer registration now open in the Battlefords  battlefordsNOW

Indoor soccer registration now open in the Battlefords - battlefordsNOW

Click here to get full coverage on 12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session  Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Click here to get full coverage on U of A program aims to support Black students in social innovation - thegatewayonline.ca

U of A program aims to support Black students in social innovation  thegatewayonline.ca

U of A program aims to support Black students in social innovation - thegatewayonline.ca

Click here to get full coverage on Allied Tech appoints IFA for acquisition offer from bYSI founder’s car rental company - The Business Times

Allied Tech appoints IFA for acquisition offer from bYSI founder’s car rental company  The Business Times

Allied Tech appoints IFA for acquisition offer from bYSI founder’s car rental company - The Business Times

Click here to get full coverage on Allied Tech’s independent chairman and CEO ousted from board - The Business Times

Allied Tech’s independent chairman and CEO ousted from board  The Business Times

Allied Tech’s independent chairman and CEO ousted from board - The Business Times

Click here to get full coverage on Embattled Prince Holding Group Linked to Singaporean Car-Financing Industry - Asia Sentinel

Embattled Prince Holding Group Linked to Singaporean Car-Financing Industry  Asia Sentinel

Embattled Prince Holding Group Linked to Singaporean Car-Financing Industry - Asia Sentinel

Click here to get full coverage on Hopes that BeyondSpring will blossom on Nasdaq listing - The Pharma Letter

Hopes that BeyondSpring will blossom on Nasdaq listing  The Pharma Letter

Hopes that BeyondSpring will blossom on Nasdaq listing - The Pharma Letter

Click here to get full coverage on Allied Tech independent chairman, CEO ousted from board - The Straits Times

Allied Tech independent chairman, CEO ousted from board  The Straits Times

Allied Tech independent chairman, CEO ousted from board - The Straits Times

Click here to get full coverage on Offer for Allied Technologies ‘not fair and not reasonable’: IFA - The Business Times

Offer for Allied Technologies ‘not fair and not reasonable’: IFA  The Business Times

Offer for Allied Technologies ‘not fair and not reasonable’: IFA - The Business Times

Click here to get full coverage on SRS Auto Holdings raises Allied Tech offer price to S$0.011 - The Business Times

SRS Auto Holdings raises Allied Tech offer price to S$0.011  The Business Times

SRS Auto Holdings raises Allied Tech offer price to S$0.011 - The Business Times

Click here to get full coverage on SRS Auto Holdings’ offer for Allied Tech turns unconditional - The Business Times

SRS Auto Holdings’ offer for Allied Tech turns unconditional  The Business Times

SRS Auto Holdings’ offer for Allied Tech turns unconditional - The Business Times

Click here to get full coverage on BYSI store opens in Dubai - PressReader

BYSI store opens in Dubai - PressReader

Click here to get full coverage on BeyondSpring (NASDAQ:BYSI) Shares Down 4.2% – Should You Sell? - Defense World

BeyondSpring (NASDAQ:BYSI) Shares Down 4.2% – Should You Sell?  Defense World

BYSI

Price Chart

Key Statistics

Technicals

About BYSI

Latest News

BYSI Stock Shows Turbulence Amid Financial Uncertainty - StocksToTrade

BeyondSpring (NASDAQ: BYSI) Phase 3 Asian data shows HR 0.69, cuts neutropenia to 3.9% - Stock Titan

BeyondSpring Inc. (NASDAQ:BYSI) Sees Large Increase in Short Interest - MarketBeat

Advanced Charts

Top Gainers

Top Losers